Pterostilbene restores carbapenem susceptibility in New Delhi metallo‐β‐lactamase‐producing isolates by inhibiting the activity of New Delhi metallo‐β‐lactamases

Autor: Yang Wang, Jian Zhang, Naiyu Hu, Yonglin Zhou, Jianfeng Wang, Shui Liu, Jiyun Li, Xuming Deng, Xiaodi Niu
Rok vydání: 2019
Předmět:
Zdroj: Br J Pharmacol
ISSN: 1476-5381
0007-1188
Popis: BACKGROUND AND PURPOSE: Bacteria producing New Delhi metallo‐β‐lactamase‐1 (NDM‐1) are an increasing clinical threat. NDM‐1 can inactivate almost all β‐lactams and is not sensitive to any existing β‐lactamase inhibitors. To identify effective inhibitors of the NDM‐1 enzyme and clarify the mechanism of action, a “lead compound” for developing more potent NDM‐1 inhibitors needs to be provided. EXPERIMENTAL APPROACH: Natural compounds were tested by enzyme inhibition screening to find potential inhibitors. MIC assays, growth curve assays, and time‐kill assays were conducted to evaluate the in vitro antibacterial activity of pterostilbene and the combination of pterostilbene and meropenem. A murine thigh model and a mouse https://academic.oup.com/jac/article-abstract/54/6/1085/856174 model were used to evaluate the in vivo efficacy of combined therapy. Molecular modelling and a mutational analysis were used to clarify the mechanism of action. KEY RESULTS: Pterostilbene significantly inhibited NDM‐1 hydrolysis activity in enzyme inhibition screening assays and effectively restored the effectiveness of meropenem in vitro with NDM‐expressing isolates in antibacterial activity assays. In addition, the combined therapy effectively reduced the bacterial burden in a murine thigh model and protected mice from https://academic.oup.com/jac/article-abstract/54/6/1085/856174 caused by Klebsiella pneumoniae. By means of molecular dynamics simulation, we observed that pterostilbene localized to the catalytic pocket of NDM‐1, hindering substrate binding to NDM‐1 and reducing NDM‐1 activity. CONCLUSIONS AND IMPLICATIONS: These findings indicated that pterostilbene combined with meropenem may offer a new safe and potential “lead compound” for the further development of NDM‐1 inhibitors.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje